Table 4.
Strategies to improve translation of gnotobiotic murine model results to human application.
| 1. Use clinically relevant human microbial strains for selective colonization |
| 2. Collect specimens from donors with important clinical disease phenotypes and matched healthy controls for FMT → “humanized” ex-GF mice |
| 3. Validate results in at least two separate recipient GF strains or different inflammatory models, preferably with different mechanism of disease induction |
| 4. For therapeutic studies, use treatment as well as preventive protocols |
| 5. Cautiously interpret results |